Literature DB >> 15976610

The management of malodour and exudate in fungating wounds.

Charlotte Draper1.   

Abstract

The topic of malodour and exudate in fungating wounds is of particular interest and relevance for community nurses who care for patients with fungating wounds in the community setting. Community nurses can work together with community oncology and palliative care services to manage patients with fungating wounds at home, where once hospital admission would have been needed to provide the level of support and care these patients require. Fungating wounds present unique challenges and can be problematic as a result of the levels of exudate and malodour which they produce. This review sought to establish whether recent advances in wound care products and/or techniques, could be of value in the control of these symptoms. The review established that there is little clinical research into the care of fungating wounds, and that the development of new dressings and techniques for controlling malodour and exudate is badly needed.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15976610     DOI: 10.12968/bjon.2005.14.Sup2.18210

Source DB:  PubMed          Journal:  Br J Nurs        ISSN: 0966-0461


  3 in total

1.  An intense and unforgettable experience: the lived experience of malignant wounds from the perspectives of patients, caregivers and nurses.

Authors:  Susan J Alexander
Journal:  Int Wound J       Date:  2010-12       Impact factor: 3.315

Review 2.  Care of chronic wounds in palliative care and end-of-life patients.

Authors:  Christine A Chrisman
Journal:  Int Wound J       Date:  2010-05-28       Impact factor: 3.315

3.  Management of malignant cutaneous wounds in oncologic patients.

Authors:  Michela Starace; Miriam Anna Carpanese; Francesca Pampaloni; Emi Dika; Alessandro Pileri; Daniela Rubino; Aurora Alessandrini; Claudio Zamagni; Carlotta Baraldi; Cosimo Misciali; Annalisa Patrizi; Tommaso Bianchi; Zoe Apalla; Bianca Maria Piraccini
Journal:  Support Care Cancer       Date:  2022-06-08       Impact factor: 3.359

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.